Neogenomics (NEO) Doubles Q2 EPS Estimates
Neogenomics (NASDAQ: NEO) reported Q3 EPS of $0.02, $0.01 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
